Recombinant multi-species Cyclophilin A/PPIA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Cyclophilin A/PPIA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the peptidyl-prolyl cis-trans isomerase (PPIase) family. PPIases catalyze the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and accelerate the folding of proteins. The encoded protein is a cyclosporin binding-protein and may play a role in cyclosporin A-mediated immunosuppression. The protein can also interact with several HIV proteins, including p55 gag, Vpr, and capsid protein, and has been shown to be necessary for the formation of infectious HIV virions. Multiple pseudogenes that map to different chromosomes have been reported. [provided by RefSeq, Jul 2008]
The Alternative Names of target: CYCA,CYPA,CYPH,Cphn,CyP-18,CyP-A,Cyclophilin A,Cyclosporin A-binding protein,CypA,HEL-S-69p,MT-ND1,MTND1,NADH1,ND1,PPIA,PPIase A,Peptidyl-prolyl cis-trans isomerase A,Ppia,Rotamase A,SP18,cypA,p1B15,p31

Target products collectionGo to Cyclophilin A/PPIA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T47081-Ag-1/ GM-Tg-hg-T47081-Ag-2 Human Cyclophilin A/PPIA protein Human
GM-Tg-rg-T47081-Ag-1/ GM-Tg-rg-T47081-Ag-2 Rat Cyclophilin A/PPIA protein Rat
GM-Tg-mg-T47081-Ag-1/ GM-Tg-mg-T47081-Ag-2 Mouse Cyclophilin A/PPIA protein Mouse
GM-Tg-cynog-T47081-Ag-1/ GM-Tg-cynog-T47081-Ag-2 Cynomolgus/Rhesus macaque Cyclophilin A/PPIA protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T47081-Ag-1/ GM-Tg-felg-T47081-Ag-2 Feline Cyclophilin A/PPIA protein Feline
GM-Tg-cang-T47081-Ag-1/ GM-Tg-cang-T47081-Ag-2 Canine Cyclophilin A/PPIA protein Canine
GM-Tg-bovg-T47081-Ag-1/ GM-Tg-bovg-T47081-Ag-2 Bovine Cyclophilin A/PPIA protein Bovine
GM-Tg-equg-T47081-Ag-1/ GM-Tg-equg-T47081-Ag-2 Equine Cyclophilin A/PPIA protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T47081-Ag-1/ GM-Tg-hg-T47081-Ag-2; GM-Tg-rg-T47081-Ag-1/ GM-Tg-rg-T47081-Ag-2;
GM-Tg-mg-T47081-Ag-1/ GM-Tg-mg-T47081-Ag-2; GM-Tg-cynog-T47081-Ag-1/ GM-Tg-cynog-T47081-Ag-2;
GM-Tg-felg-T47081-Ag-1/ GM-Tg-felg-T47081-Ag-2; GM-Tg-cang-T47081-Ag-1/ GM-Tg-cang-T47081-Ag-2;
GM-Tg-bovg-T47081-Ag-1/ GM-Tg-bovg-T47081-Ag-2; GM-Tg-equg-T47081-Ag-1/ GM-Tg-equg-T47081-Ag-2
Products Name Cyclophilin A/PPIA protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Cyclophilin A/PPIA
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Cyclophilin A/PPIA protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.